Skip to content
- Pharmacy
- October 4, 2021
- 2 min read
Novel Approach Using Administrative Claims to Evaluate Trends in Oncology Multigene Panel Testing for Patients Enrolled in Medicare Advantage Health Plans
- Eleanor O. Caplan, PharmD, PhD; William B. Wong , PharmD, MS; Erin Ferries, PhD, MPH; Rebecca Hulinsky, MS; Vicky T. Brown , PharmD; Kristine Bordenave, MD; Brandon T. Suehs, PharmD, PhD
Read More
- Pharmacy
- July 8, 2021
- 2 min read
Cardiovascular Risk in Users of Mirabegron Compared with Users of Antimuscarinic Treatments for Overactive Bladder: Findings from a Non-Interventional, Multinational, Cohort Study
- Veena Hoffman; Jesper Hallas; Marie Linder; Andrea V Margulis; Brandon T Suehs; Alejandro Arana; Kelesitse Phiri; Cheryl Enger; Libby Horter; Ingvild Odsbu; Morten Olesen; Susana Perez-Gutthann; Yihua Xu; Nina Sahlertz Kristiansen; Kwame Appenteng; Stefan de Vogel; John D Seeger; mirabegron PMR-PASS study group
Read More
- Pharmacy
- May 27, 2021
- 2 min read
Removal of Prior Authorization for Medication-Assisted Treatment: Impact on Opioid Use and Policy Implications in a Medicare Advantage Population.
- Erin Ferries, PhD, MPH; Patrick Racsa, MPH; Brock Bizzell, PharmD, MBA; Clay Rhodes, PharmD, MBA; Brandon Suehs , PharmD, PhD
Read More
- Pharmacy
- May 27, 2021
- 2 min read
Glomerular filtration rate change and outcomes in type 2 diabetes
- Eleanor O Caplan; Richard Sheer; Niklas Schmedt; Thomas Evers; Meghan Cockrell; Michael Tindal; Margaret K Pasquale; Csaba P Kovesdy
Read More
- Pharmacy
- April 9, 2021
- 1 min read
A Real-World Comparison of Cardiovascular, Medical and Costs Outcomes in New Users of SGLT2 Inhibitors versus GLP-1 Agonists
- Insiya B Poonawalla; Andy T Bowe; Michael C Tindal; Yunus A Meah; Phil Schwab
Read More